December 23，CFDA Hold the Starting Meeting and Seminar of the Revision of the Drug Management Law，This means the revision of the long -breaking "Drug Management Law" finally opened the curtain。
 
CFDA Represents，The current "Drug Management Law" can no longer meet the needs of supervision and development.。Enhance the protection of subjects in clinical trials of drugs、Improve the management of drug use links、Increasing punishment for illegal acts is the main content of the revision。Where，Change the light process supervision、Increased the content of the punishment of illegal acts attracted much attention，The industry stake betting appbelieves stake sports betting appthat this is the government's simplified administration and decentralization、Clarify the important performance of government and corporate responsibilities。
 
Yu Mingde, chairman of the China Medical Enterprise Management Association, told reporters，The revised industry of "Drug Management Law" is long -awaited，Related surveys have begun two years ago，After the official startup，Many policies that are unfavorable to the development of the industry are expected to be broken。
 
CFDA said in the official press release，Existing regulations are inadequate。If the administrative approval and postponement of the post -incident，Light process supervision; heavy administrative punishment，Light Civil、Criminal and other responsibilities forms，At the same time for the new situation、New Questions、Lack of corresponding regulations for new means。Such as retail chain operation、third -party logistics、Drug export、Accessories Management、Drug recall and other means lack of legal basis，Impact implementation effect。With the deepening of the reform of the administrative system and the change of government functions，It is also important to modify the relevant terms of the Drug Management Law and the integration of international drug management laws and regulations.。
 
Guo Fanli, Manager of the Research Department of China Investment Advisory Industry, told reporters，CFDA's revision of the Drug Management Law，Very stake betting appreflecting the principle of advancing stake sports betting appwith the times，For example，The increasing development of the Internet，Online pharmacies can facilitate consumers to purchase medicines，Reduce the cost of rental for merchants，Let the consumer in the medicine，allows consumers and merchants to achieve & ldquo; win -win & rdquo;。Revised Draft to increase the content of the regulatory Internet drug transaction。
 
but，Online pharmacies have a greater impact on physical retail pharmacies，Because in terms of cost or price，Online pharmacies have more advantages than physical pharmacies，physical pharmacies should improve the service level of a single store，can we compete with it。
 
In terms of drug listing permit，As an industry representative，Yu Mingde, chairman of the China Medical Enterprise Management Association，At present, some policies have caused obstacles to the development of the industry。For example。
 
It is understood，At present, domestic drugs are implemented in the production license system，Units applying for drug approval text must be a production unit，Enterprises can only produce their own research and development、Products to get batch number。and the need for medicine from research and development to obtaining batch numbers require huge investment and long cycle，Many production capacity can only be idle。
 
China Foreign Investment Enterprise Association Drug Development and Development stake online sports bettingIndustry Committee (RDPAC) said stake online sports bettingin a previous research report，Since the approval number of Chinese drugs is only awarded to the manufacturer，R & D institutions can only benefit through technology transferrs，Short -eye behavior is very common，& ldquo; Driven bomb & rdquo; difficult to appear; my country's current laws of the relevant & ldquo; research and development of the obligations and responsibilities of drugs after listing & rdquo;，As a result, some hidden dangers and signs that should have received attention in research and development，I was ignored due to the no responsibility of the developer in the future。
 
Yu Mingde suggested to learn from the successful experience of domestic drugs such as Europe and the United States。
 
It is understood，U.S., Europe and Japan and other developed countries and regions and regions are generally adopted by the listing license system (MAH)，is the separation of the pharmaceutical listing permit from the production permit。Those who obtain a drug listing permit can be an enterprise、Scientific Institute、Social Organization，After obtaining the drug approval number，You can produce yourself，You can also entrust to produce with different manufacturers。such as，Pfizer、Bayer、Grammomsk and other companies，Generally conducting drug research and development，Transfer or commission processing of production links。This makes the drug listing licensee more focused stake betting appon research and development，Control Stake Sports Bettingthe high -end industrial chain，Make R & D and production better。Entrusted manufacturers are more focused on the production process，Realized the professional division of labor of the industrial chain。